Syncom Formulations Promoters Submit Yearly Disclosure Under SEBI (SAST) Regulations 2011
Syncom Formulations' Promoters, Shri Kedarmal Shankarlal Bankda and Shri Vijay Shankarlal Bankda, have submitted their yearly disclosure for the financial year ended March 31, 2026, as per SEBI (SAST) Regulations, 2011. The disclosure was made to the company's Audit Committee and the stock exchanges.
This is a standard disclosure requirement under SEBI regulations for promoters and does not represent a new event or development that would significantly impact the company's operations or stock price.
The announcement is a routine regulatory filing regarding promoter disclosures and does not contain information that positively or negatively impacts the company's financial performance or outlook.
Syncom Formulations (India) Limited announced that pursuant to Regulation 31(4) of SEBI (SAST) Regulations, 2011, its Promoters, Shri Kedarmal Shankarlal Bankda and Shri Vijay Shankarlal Bankda, along with their Persons Acting in Concert (PAC), have provided their Yearly Disclosure for the financial year ended 31st March, 2026. This disclosure was submitted to the Audit Committee of the Company. The Promoters have also submitted their disclosures to the BSE Limited and the National Stock Exchange of India Limited. The company is forwarding this information for reference and requests the exchanges to host it on their websites.
What to do with a filing like this
Syncom Formulations (India) Limited filed this with the NSE as a statutory disclosure, categorised under substantial acquisition of shares and takeovers. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Syncom Formulations (India) Limited. Read the original for the full detail.